← Leaderboards
James P McGettigan
Thomas Jefferson University
$4,864,002
Attributed
$4,864,002
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $987.9K · FY2006–18$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$4,864,002 · 10
By mechanism
R01$2,091,641 · 2
R21$1,415,431 · 4
R42$829,600 · 1
R56$351,000 · 1
R41$162,433 · 1
P51$13,897 · 1
Top collaborators
No co-investigators on record.
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Milosz Andrzej Faber$2,338,938
Others in their field
Top investigators on “Dose”
- Lawrence Corey · Fred Hutchinson Cancer Center$251,944,397
- Sharon A Nachman · Johns Hopkins University$213,337,729
- David Heimbrook · Leidos Biomedical Research, Inc.$146,807,554
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$134,297,561
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Peter C Adamson · National Childhood Cancer Foundation$122,197,823
Research focus
DoseVaccinesBaseRabies VirusVirusRabies VaccinesProphylactic TreatmentImmunogenicityVaccinationCostRabiesVirus DiseasesImmunityLaboratoriesPreventionCessation Of LifeGenesResponsePreventVectorLifeSiteChildKinetics
Grant awards (18)
Development of a single-dose rabies virus vaccine$390,000
R01 · FY2018 · AI · contact PI
Development of Rabies-based Virus-like Particles$195,000
R21 · FY2018 · AI · contact PI
Development of a single-dose rabies virus vaccine$214,500
R01 · FY2017 · AI · contact PI
Development of a single-dose rabies vaccine$351,000
R56 · FY2016 · AI · contact PI
Novel rabies virus vaccines that exploit innate immune signals$232,500
R21 · FY2015 · AI · contact PI
Novel rabies virus vaccines that exploit innate immune signals$193,750
R21 · FY2014 · AI · contact PI
Antibody Responses to a Novel HIV-1 Vaccine Vector$218,550
R21 · FY2013 · AI · contact PI
Human Rabies Virus Vaccine Development$415,582
R42 · FY2012 · AI · contact PI
Replication-deficient rabies vectors against rabies infection$378,564
R01 · FY2012 · AI · contact PI
Antibody Responses to a Novel HIV-1 Vaccine Vector$193,750
R21 · FY2012 · AI · contact PI
Human Rabies Virus Vaccine Development$414,018
R42 · FY2011 · AI · contact PI
Replication-deficient rabies vectors against rabies infection$378,564
R01 · FY2011 · AI · contact PI
Replication-deficient rabies vectors against rabies infection$382,388
R01 · FY2010 · AI · contact PI
Replication-deficient rabies vectors against rabies infection$347,625
R01 · FY2009 · AI · contact PI
Human Rabies Virus Vaccine Development$162,433
R41 · FY2009 · AI · contact PI
IMMUNOGENICITY OF REPLICATION-DEFICIENT RABIES VIRUS VECTORS IN NHPS$13,897
P51 · FY2008 · RR · contact PI
Second Generation Rabies Vaccines$188,131
R21 · FY2007 · AI · contact PI
Second Generation Rabies Vaccines$193,750
R21 · FY2006 · AI · contact PI